Markets: EMA (EU), MHRA (UK), FDA (USA), PMDA (Japan), Health Canada (Canada)
Batch Size: Large, Small, Medium
Compliance: ISO, FDA (cGMP), EMA (EU GMP)
Controlled Substances: Lowest potential for abuse, Lower potential for abuse, Low potential for abuse, High potential for abuse & medical use
Services: Development services, Analytical / QC services, Manufacturing services
Use: Human, Veterinary
OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)
Therapeutic Areas of Expertise (ATC): (D) Dermatologicals, (N) Nervous system, (H) Systemic hormonal preparations excl. sex hormones and insulins
Category / Product: FDF / DRUG PRODUCTS
Region: Europe
Are you a pharmaceutical company seeking a reliable CMO or CDMO partner to accelerate your drug development process? Look no further than MAI CDMO Network. Our advanced search platform connects you with a vast network of qualified contract manufacturers and development organizations worldwide.
Why Choose MAI CDMO Network?
How MAI CDMO Network Works
Key Benefits of Partnering with a CMO/CDMO
Featured Services
Ready to Find Your Ideal CMO/CDMO Partner? Register Now
Explore our platform today and discover how MAI CDMO Network can help you achieve your drug development goals.